Therefore, blocking the PD-1/PD-L1 inhibitory pathway can activate T cells in the TME, releasing inflammatory cytokines and cytotoxic granules to eliminate tumor cells (Fig. 2). This evidence concerns the gene CD274 and neoplasm.